Chemed Reports Mixed Q3 2025 Earnings Performance

Chemed ( (CHE) ) has released its Q3 earnings. Here is a breakdown of the information Chemed presented to its investors.

Chemed Corporation is a diversified company operating in the healthcare and plumbing sectors, primarily through its subsidiaries VITAS Healthcare Corporation and Roto-Rooter. VITAS is the largest provider of end-of-life care in the United States, while Roto-Rooter is the leading provider of plumbing and drain cleaning services in North America.

In its third-quarter 2025 earnings report, Chemed Corporation reported a 3.1% increase in revenue to $624.9 million compared to the same period last year. However, the company experienced a decline in profitability, with GAAP diluted earnings per share (EPS) decreasing by 10.8% to $4.46 and adjusted diluted EPS falling by 6.6% to $5.27.

The VITAS segment saw a 4.2% increase in net patient revenue to $407.7 million, driven by a rise in admissions and average daily census. Despite this growth, VITAS faced challenges with a 9.0% decrease in net income and a 3.8% decline in adjusted EBITDA. The Roto-Rooter segment also experienced a modest revenue increase of 1.1% to $217.2 million, but net income decreased by 14.8%, and adjusted EBITDA fell by 12.4%.

Chemed’s financial position remains robust with $129.8 million in cash and cash equivalents and no current or long-term debt. The company continues to manage its capital efficiently, repurchasing shares worth $180.8 million during the quarter. Chemed’s management has reiterated its full-year guidance for 2025, expecting adjusted EPS to range between $22.00 and $22.30.

Looking ahead, Chemed remains focused on navigating the challenges in its operating environment while leveraging its strong market positions in both the healthcare and plumbing sectors. The company aims to sustain revenue growth and improve operational efficiencies to enhance shareholder value.